	Deutsch English Français Español Türkçe Polski Русский Rumână Українська العربية



	Home About Contact

Please support THE CITIZEN'S VOICE with a donation HERE!

LEGAL VICTORY AGAINST BIONTECH - Public statement by Katharina Koenig

Topic: Success of the law firm Rogert & Ulbrich – Why are mainstream and independent media remaining silent about the landmark ruling in Aurich?

My name is Katharina Koenig. Today I am addressing the public to speak about a massive legal breakthrough that has been almost completely ignored in current reporting. The law firm Rogert & Ulbrich has obtained a landmark partial judgment against BioNTech before the Regional Court of Aurich.

This ruling obliges the manufacturer to provide comprehensive disclosure on a catalogue of 32 highly sensitive points. This is not about speculation, but about a court-ordered disclosure of data regarding the safety, production, and biological effects of the mRNA preparations that have so far been kept under wraps.

The questionnaire for full clarification:

1. Exact lipid composition: What is the precise mixing ratio of the four lipids used?

2. Integrity of mRNA: What proportion of the mRNA was intact and what proportion was fragmented?

3. DNA contamination: Information on residues of plasmid DNA from the manufacturing process.

4. Identity of all excipients: A complete list of all added substances and their purity.

5. Batch variability: Why do adverse event reports differ so drastically between different production batches?

6. mRNA stability: Documentation on degradation products and their potential toxicity.

7. Organ biodistribution: Where exactly do the particles (LNPs) accumulate in the human body?

8. Duration of spike production: For how long do cells produce the protein after injection?

9. Quantification of spike protein: What is the concentration of the produced protein in the bloodstream?

10. Cell specificity: Which cell types does the mRNA preferentially enter?

11. Barrier crossing: Data on passage across the blood-brain barrier and the placenta.

12. Comprehensive adverse event reports: All reports available worldwide to the manufacturer regarding side effects.

13. Severity analysis: Details on the intensity and duration of reported health damage.

14. Cardiovascular risks: Specific data on myocarditis, heart attacks, and strokes.

15. Neurological diseases: Documentation on paralysis, nerve damage, and autoimmune processes.

16. Death case documentation: All reports occurring in temporal proximity to vaccine administration.

17. Long-term toxicity: Safety data from observational studies over several years.

18. Individual Patient Data: Anonymized individual subject data from the original approval trials.

19. Exclusion analyses: Why were certain participants removed from the final study evaluation?

20. Placebo unblinding: Why was the control group vaccinated early, making long-term comparisons more difficult?

21. Infection transmission: Was there scientific evidence at market launch of protection of third parties?

22. Interaction studies: Findings on interactions with other medications or vaccines.

23. Warning history: From what point in time did the manufacturer have information about specific risks?

24. Regulatory correspondence: Full disclosure of communication with the PEI and the EMA.

25. Safety reports (PSURs): All periodic status reports submitted to regulatory authorities.

26. Liability arrangements: According to contracts, who bears financial responsibility for damages that occurred?

27. Reverse transcription: Studies on possible integration of mRNA sequences into human DNA.

28. Antibody-dependent enhancement (ADE): Risk assessment of possible worsening of infections.

29. Reproductive toxicity: Data on effects on fertility and the female cycle.

30. Oncogenic potential: Investigations into cancer growth or reactivation of tumors.

31. Immunosuppression: Findings on weakening of the general immune response after vaccination.

32. Quality control: Who carried out final batch release and what defects were documented?

My question to the entire media landscape:

This victory by the law firm Rogert & Ulbrich before the Regional Court of Aurich is an unprecedented success for transparency. Nevertheless, both established mainstream media and many independent media outlets are almost completely ignoring this catalogue of questions and its implications.

Why is there no reporting on this legal breakthrough and the resulting obligation to provide information? Journalism has a duty to bring the truth to light – especially when it concerns the health of millions of people. I call on all editorial offices and independent journalists: end the silence. Ask the questions that are now legally validated.

Author: AI-Translation - Katharina Koenig |

Jeden Tag neue Angebote bis zu 70 Prozent reduziert

Other articles:

Naumburg Children Week(s) from May 30 to June 13, 2025

Fun, games, and excitement for little explorers: From May 30 to June 13, 2025, the Naumburg Children’s Week invites kids to a wide range of events — from cathedral adventures a... zum Artikel

Steel Meets Imagination: Art and Technology at the Model Railway Wiehe

A trip full of surprises: The Model Railway Wiehe not only showcases fascinating miniature worlds but also currently invites visitors to an exhibition of impressive metal sculpture... zum Artikel

55 Cents per Liter of Diesel – Hohenmölsen Implements the Fuel Price Cap

The energy revolution in the Saxony-Anhalt town will enter its next phase: After Hohenmölsen was announced as the first CO₂-neutral city in Germany, Mayor Andy Haugk will presen... zum Artikel